DK1339695T3 - Farnesyltransferase-inhibitorer - Google Patents

Farnesyltransferase-inhibitorer

Info

Publication number: DK1339695T3
Authority: DK; Denmark
Prior art keywords: transferase inhibitors; farnesyl transferase; farnesyl; inhibitors; transferase
Prior art date: 2000-11-30

Application number

DK01273519T

Other languages

English (en)

Inventor

Akiyo K Claiborne

Stephen L Ii Gwaltney

Tomgmei Li

Robert A Mantei

Todd W Rockway

Yunsong Tong

Gary T Wang

Xilu Wang

Weibo Wang

Lisa A Hasvold

Qun Li

Nan-Horng Lin

Hing L Sham

Gerard M Sullivan

Le Wang

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-11-30

Filing date

2001-11-30

Publication date

2006-07-31

2001-11-30 Application filed by Abbott Lab filed Critical Abbott Lab

2006-07-31 Application granted granted Critical

2006-07-31 Publication of DK1339695T3 publication Critical patent/DK1339695T3/da

Links

239000003528 protein farnesyltransferase inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

DK01273519T 2000-11-30 2001-11-30 Farnesyltransferase-inhibitorer DK1339695T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US72723000A	2000-11-30	2000-11-30
US09/912,677 US20020115640A1 (en)	2000-11-30	2001-07-25	Farnesyltransferase inhibitors

Publications (1)

Publication Number	Publication Date
DK1339695T3 true DK1339695T3 (da)	2006-07-31

Family

ID=24921844

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01273519T DK1339695T3 (da)	2000-11-30	2001-11-30	Farnesyltransferase-inhibitorer

Country Status (30)

Country	Link
US (1)	US20020115640A1 (da)
EP (1)	EP1339695B1 (da)
JP (1)	JP2004519503A (da)
KR (1)	KR20030060968A (da)
CN (1)	CN1487924A (da)
AR (1)	AR035375A1 (da)
AT (1)	ATE323681T1 (da)
BG (1)	BG107908A (da)
BR (1)	BR0112028A (da)
CA (1)	CA2430619A1 (da)
CY (1)	CY1106104T1 (da)
CZ (1)	CZ20031804A3 (da)
DE (1)	DE60118955T2 (da)
DK (1)	DK1339695T3 (da)
EC (1)	ECSP034634A (da)
ES (1)	ES2261340T3 (da)
HU (1)	HUP0600331A2 (da)
IL (2)	IL156212A0 (da)
MX (1)	MXPA03004879A (da)
MY (1)	MY136181A (da)
NO (1)	NO20032471L (da)
NZ (1)	NZ526313A (da)
PE (1)	PE20020687A1 (da)
PL (1)	PL363637A1 (da)
PT (1)	PT1339695E (da)
SA (1)	SA01220565B1 (da)
SI (1)	SI1339695T1 (da)
SK (1)	SK286686B6 (da)
UY (1)	UY27046A1 (da)
WO (1)	WO2002074747A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008539276A (ja) *	2005-04-27	2008-11-13	ユニバーシティオブフロリダリサーチファウンデーション，インコーポレイティド	ヒト疾患に関連する変異体タンパク質の分解能を改善するための材料及び方法
JP4592548B2 (ja) *	2005-08-24	2010-12-01	株式会社エヌ・ティ・ティ・ドコモ	送信電力制御方法及び移動通信システム
US7722316B2 (en) *	2005-09-13	2010-05-25	Rolls-Royce Power Engineering Plc	Acoustic viscous damper for centrifugal gas compressor
US7790770B2 (en)	2005-11-23	2010-09-07	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
TW200806284A (en) *	2006-03-31	2008-02-01	Alcon Mfg Ltd	Prenyltransferase inhibitors for ocular hypertension control and the treatment of glaucoma
US8084477B2 (en) *	2007-10-31	2011-12-27	Bristol-Myers Squibb Company	Alpha-(N-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
US20110086834A1 (en) *	2008-06-26	2011-04-14	Amgen Inc.	Alkynyl alcohols as kinase inhibitors
WO2012069193A1 (de) *	2010-11-26	2012-05-31	Reza Ghotbi	Implant zur behandlung oder prävention eines aneurysmas
CN105693617B (zh) *	2014-11-24	2018-06-08	中国科学院大连化学物理研究所	一种tmsn3参与的还原环化反应制备4-咪唑甲醛衍生物的方法
EP3902100A1 (en)	2015-10-07	2021-10-27	Tc1 Llc	Resonant power transfer systems having efficiency optimization based on receiver impedance
WO2018132791A1 (en)	2017-01-16	2018-07-19	The Regents Of The University Of California	Treatment of neurodegenerative conditions by disruption of rhes
CN112851508B (zh) *	2019-11-27	2025-02-25	广东东阳光药业股份有限公司	一种巴洛沙韦中间体的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0891361A1 (en) *	1996-04-03	1999-01-20	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US6297239B1 (en) *	1997-10-08	2001-10-02	Merck & Co., Inc.	Inhibitors of prenyl-protein transferase
ATE289602T1 (de) *	1998-08-27	2005-03-15	Pfizer Prod Inc	Quinolin-2-on-derivate verwendbar als antikrebsmittel

2001
- 2001-07-25 US US09/912,677 patent/US20020115640A1/en not_active Abandoned
- 2001-10-24 MY MYPI20014939A patent/MY136181A/en unknown
- 2001-11-29 AR ARP010105568A patent/AR035375A1/es unknown
- 2001-11-29 PE PE2001001198A patent/PE20020687A1/es not_active Application Discontinuation
- 2001-11-29 UY UY27046A patent/UY27046A1/es not_active Application Discontinuation
- 2001-11-30 SI SI200130573T patent/SI1339695T1/sl unknown
- 2001-11-30 EP EP01273519A patent/EP1339695B1/en not_active Expired - Lifetime
- 2001-11-30 ES ES01273519T patent/ES2261340T3/es not_active Expired - Lifetime
- 2001-11-30 CA CA002430619A patent/CA2430619A1/en not_active Abandoned
- 2001-11-30 JP JP2002573756A patent/JP2004519503A/ja active Pending
- 2001-11-30 IL IL15621201A patent/IL156212A0/xx active IP Right Grant
- 2001-11-30 SK SK823-2003A patent/SK286686B6/sk not_active IP Right Cessation
- 2001-11-30 PL PL01363637A patent/PL363637A1/xx not_active Application Discontinuation
- 2001-11-30 KR KR10-2003-7007345A patent/KR20030060968A/ko not_active Ceased
- 2001-11-30 CZ CZ20031804A patent/CZ20031804A3/cs unknown
- 2001-11-30 AT AT01273519T patent/ATE323681T1/de not_active IP Right Cessation
- 2001-11-30 NZ NZ526313A patent/NZ526313A/en unknown
- 2001-11-30 HU HU0600331A patent/HUP0600331A2/hu unknown
- 2001-11-30 PT PT01273519T patent/PT1339695E/pt unknown
- 2001-11-30 DK DK01273519T patent/DK1339695T3/da active
- 2001-11-30 DE DE60118955T patent/DE60118955T2/de not_active Expired - Fee Related
- 2001-11-30 BR BR0112028-0A patent/BR0112028A/pt not_active IP Right Cessation
- 2001-11-30 CN CNA018223427A patent/CN1487924A/zh active Pending
- 2001-11-30 WO PCT/US2001/043168 patent/WO2002074747A1/en not_active Ceased
- 2001-11-30 MX MXPA03004879A patent/MXPA03004879A/es active IP Right Grant
- 2001-12-02 SA SA01220565A patent/SA01220565B1/ar unknown
2003
- 2003-05-29 IL IL156212A patent/IL156212A/en not_active IP Right Cessation
- 2003-05-30 NO NO20032471A patent/NO20032471L/no not_active Application Discontinuation
- 2003-05-30 EC EC2003004634A patent/ECSP034634A/es unknown
- 2003-06-13 BG BG107908A patent/BG107908A/bg unknown
2006
- 2006-06-23 CY CY20061100852T patent/CY1106104T1/el unknown

Also Published As

Publication number	Publication date
AR035375A1 (es)	2004-05-12
CA2430619A1 (en)	2002-09-26
NO20032471L (no)	2003-07-25
SI1339695T1 (sl)	2006-10-31
NZ526313A (en)	2004-11-26
SK8232003A3 (en)	2004-01-08
EP1339695A1 (en)	2003-09-03
ES2261340T3 (es)	2006-11-16
ECSP034634A (es)	2003-07-25
IL156212A (en)	2008-11-26
SA01220565B1 (ar)	2007-01-27
UY27046A1 (es)	2002-07-31
MY136181A (en)	2008-08-29
BR0112028A (pt)	2004-02-17
DE60118955T2 (de)	2007-01-04
CY1106104T1 (el)	2011-06-08
KR20030060968A (ko)	2003-07-16
BG107908A (bg)	2004-01-30
HK1059260A1 (en)	2004-06-25
NO20032471D0 (no)	2003-05-30
CN1487924A (zh)	2004-04-07
PE20020687A1 (es)	2002-08-03
WO2002074747A1 (en)	2002-09-26
ATE323681T1 (de)	2006-05-15
EP1339695B1 (en)	2006-04-19
PL363637A1 (en)	2004-11-29
IL156212A0 (en)	2003-12-23
MXPA03004879A (es)	2004-05-04
CZ20031804A3 (cs)	2003-11-12
SK286686B6 (sk)	2009-03-05
PT1339695E (pt)	2006-08-31
DE60118955D1 (de)	2006-05-24
HUP0600331A2 (en)	2006-10-28
JP2004519503A (ja)	2004-07-02
US20020115640A1 (en)	2002-08-22

Publication	Publication Date	Title
ATE524441T1 (de)	2011-09-15	Vla-4-inhibitoren
EP1324985A4 (en)	2004-10-06	PRENYL PROTEIN TRANSFERASE INHIBITORS
CY2012007I2 (el)	2014-07-02	Πεπτιδομιμητικοι αναστολεις πρωτεασης
NO20024263D0 (no)	2002-09-06	Plugg for rör
DE69924876D1 (de)	2005-05-25	Farnesyl protein transferase inhibitoren
DK1272488T3 (da)	2006-07-17	Tri-aryl-substitueret ethan-PDE4-inhibitorer
NO20030706L (no)	2003-04-15	Substituerte imidazoler som TAFIA inhibitorer
DE60101323D1 (de)	2004-01-08	Tricyclische proteinkinasehemmer
NO20030918D0 (no)	2003-02-27	Trisykliske antitumorforbindelser som er farnesylproteintransferaseinhibitorer
ATE323681T1 (de)	2006-05-15	Farnesyltransferase inhibitoren
NO20025786L (no)	2003-02-12	Protaseinhibitorer
EE200200206A (et)	2003-04-15	Farnesüüli transferaasiinhibiitorid
NO20012961D0 (no)	2001-06-15	Trisykliske farnesylproteintransferase-inhibitorer
NO20025005D0 (no)	2002-10-17	Proteaseinhibitorer
DK1130214T3 (da)	2005-08-29	Korrosionsinhibitorer
ATE371655T1 (de)	2007-09-15	Farnesyl-protein-transferaseinhibitoren
DE60132468D1 (de)	2008-03-06	Alen-lanosterol zyklase inhibitoren
AR028075A1 (es)	2003-04-23	Inhibidores de la peptido-desformilasa
EP1222308A4 (en)	2005-02-16	INHIBITORS OF HISTONE ACETYL ANTIPROTOZOA TRANSFERASE
NO20032328L (no)	2003-07-02	Proteaseinhibitorer
ATA4972001A (de)	2005-02-15	Verteilerventil
DK1087981T3 (da)	2006-05-15	Prenyltransferaseinhibitorer
DK1296985T3 (da)	2005-10-03	Heteropolycykliske inhibitorer
IDP000027420A (id)	2001-12-20	Inhibitor-inhibitor kinase pirolotriazin
NO20002870D0 (no)	2000-06-06	MYT1 kinase inhibitorer